SOL STRATEGIES INC (STKE) Fundamental Analysis & Valuation

NASDAQ:STKE • CA83411A2056

1.51 USD
+0.04 (+2.72%)
Last: Mar 10, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This STKE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

Taking everything into account, STKE scores 1 out of 10 in our fundamental rating. STKE was compared to 242 industry peers in the Capital Markets industry. STKE has a bad profitability rating. Also its financial health evaluation is rather negative. STKE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. STKE Profitability Analysis

1.1 Basic Checks

  • STKE had negative earnings in the past year.
  • STKE had a negative operating cash flow in the past year.
  • In multiple years STKE reported negative net income over the last 5 years.
  • In the past 5 years STKE reported 4 times negative operating cash flow.
STKE Yearly Net Income VS EBIT VS OCF VS FCFSTKE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M 80M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -20.66%, STKE is doing worse than 89.26% of the companies in the same industry.
  • STKE has a Return On Equity of -30.52%. This is amonst the worse of the industry: STKE underperforms 83.47% of its industry peers.
Industry RankSector Rank
ROA -20.66%
ROE -30.52%
ROIC N/A
ROA(3y)-11.54%
ROA(5y)-7.38%
ROE(3y)-14.38%
ROE(5y)-9.17%
ROIC(3y)N/A
ROIC(5y)N/A
STKE Yearly ROA, ROE, ROICSTKE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

1.3 Margins

  • STKE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
STKE Yearly Profit, Operating, Gross MarginsSTKE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20K 40K 60K 80K 100K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. STKE Health Analysis

2.1 Basic Checks

  • STKE has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, STKE has more shares outstanding
  • STKE has a worse debt/assets ratio than last year.
STKE Yearly Shares OutstandingSTKE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
STKE Yearly Total Debt VS Total AssetsSTKE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • STKE has an Altman-Z score of -0.04. This is a bad value and indicates that STKE is not financially healthy and even has some risk of bankruptcy.
  • STKE has a worse Altman-Z score (-0.04) than 75.21% of its industry peers.
  • A Debt/Equity ratio of 0.33 indicates that STKE is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.33, STKE is in the better half of the industry, outperforming 71.07% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Altman-Z -0.04
ROIC/WACCN/A
WACCN/A
STKE Yearly LT Debt VS Equity VS FCFSTKE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • STKE has a Current Ratio of 0.11. This is a bad value and indicates that STKE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • STKE has a Current ratio of 0.11. This is amonst the worse of the industry: STKE underperforms 91.74% of its industry peers.
  • A Quick Ratio of 0.11 indicates that STKE may have some problems paying its short term obligations.
  • STKE has a Quick ratio of 0.11. This is amonst the worse of the industry: STKE underperforms 91.74% of its industry peers.
Industry RankSector Rank
Current Ratio 0.11
Quick Ratio 0.11
STKE Yearly Current Assets VS Current LiabilitesSTKE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. STKE Growth Analysis

3.1 Past

  • STKE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -426.02%.
  • The Revenue has been growing slightly by 7.49% in the past year.
  • The Revenue has been growing by 92.10% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-426.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-467.23%
Revenue 1Y (TTM)7.49%
Revenue growth 3Y66.92%
Revenue growth 5Y92.1%
Sales Q2Q%-95.54%

3.2 Future

  • Based on estimates for the next years, STKE will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.12% on average per year.
  • The Revenue is expected to decrease by -13.69% on average over the next years. This is quite bad
EPS Next Y-35.71%
EPS Next 2Y12.12%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-88.59%
Revenue Next 2Y-13.69%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
STKE Yearly Revenue VS EstimatesSTKE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 0 5M -5M 10M 15M
STKE Yearly EPS VS EstimatesSTKE Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.2 -0.4 -0.6 -0.8

More info and screens

Find the best growth stocksShow best growing peers

0

4. STKE Valuation Analysis

4.1 Price/Earnings Ratio

  • STKE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for STKE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
STKE Price Earnings VS Forward Price EarningsSTKE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STKE Per share dataSTKE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as STKE's earnings are expected to grow with 12.12% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.12%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. STKE Dividend Analysis

5.1 Amount

  • STKE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

STKE Fundamentals: All Metrics, Ratios and Statistics

SOL STRATEGIES INC

NASDAQ:STKE (3/10/2026, 8:00:01 PM)

1.51

+0.04 (+2.72%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-16
Earnings (Next)05-28
Inst Owners13.09%
Inst Owner Change46.34%
Ins Owners24.96%
Ins Owner ChangeN/A
Market Cap47.93M
Revenue(TTM)14.56M
Net Income(TTM)-35.04M
Analysts82.86
Price Target3.58 (137.09%)
Short Float %0.89%
Short Ratio0.71
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.51%
PT rev (3m)-82.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-40%
EPS NY rev (1m)-9.2%
EPS NY rev (3m)-41.79%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-26.67%
Revenue NY rev (1m)-91.83%
Revenue NY rev (3m)-91.83%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.47
P/FCF N/A
P/OCF N/A
P/B 0.57
P/tB 0.86
EV/EBITDA N/A
EPS(TTM)-1.2
EYN/A
EPS(NY)-0.71
Fwd EYN/A
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS0.34
BVpS2.66
TBVpS1.76
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -20.66%
ROE -30.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-11.54%
ROA(5y)-7.38%
ROE(3y)-14.38%
ROE(5y)-9.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 76.06%
Cap/Sales 53.42%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.11
Quick Ratio 0.11
Altman-Z -0.04
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-426.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-467.23%
EPS Next Y-35.71%
EPS Next 2Y12.12%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.49%
Revenue growth 3Y66.92%
Revenue growth 5Y92.1%
Sales Q2Q%-95.54%
Revenue Next Year-88.59%
Revenue Next 2Y-13.69%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-206.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2092.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1184.34%
OCF growth 3YN/A
OCF growth 5YN/A

SOL STRATEGIES INC / STKE FAQ

What is the ChartMill fundamental rating of SOL STRATEGIES INC (STKE) stock?

ChartMill assigns a fundamental rating of 1 / 10 to STKE.


What is the valuation status of SOL STRATEGIES INC (STKE) stock?

ChartMill assigns a valuation rating of 0 / 10 to SOL STRATEGIES INC (STKE). This can be considered as Overvalued.


How profitable is SOL STRATEGIES INC (STKE) stock?

SOL STRATEGIES INC (STKE) has a profitability rating of 0 / 10.


Can you provide the dividend sustainability for STKE stock?

The dividend rating of SOL STRATEGIES INC (STKE) is 0 / 10 and the dividend payout ratio is 0%.